Waiv products
Clinically validated digital pathology AI to augment precision oncology workflows
Transform image into action with AI diagnostics
Our products enhance patient diagnostics in 3 key ways:
Prioritize patient cases for further molecular tests by predicting those most likely to have the biomarker.
Analyze the likelihood of survival, relapse, and response to treatment to better inform targeted treatment options.
Provide quick and standard interpretation of H&E or IHC Whole Slide Images (WSIs).
Groundbreaking AI diagnostics, accessible across diverse workflows and IT settings
Minutes vs. weeks.
Software that runs on standard oncology data.
Platform agnostic and plug-and-play.
Compared with traditional tests.
Multiple analyses possible with same tissue sample.
Standardized reports at the click of a button.
.png){kind=logo}
Assess the risk of relapse in early breast cancer
.png){kind=logo}
Assessment of gBRCA mutation in breast cancer for research
.svg){kind=logo}
A workflow platform for our best-in-class AI tests
.svg){kind=logo}
Optimize MSI testing for colorectal cancer
.svg){kind=logo}
Optimize MSI testing for endometrial cancer
.svg){kind=logo}
Optimize MSI testing for gastric cancer
Detect Tertiary Lymphoid Structures across tumor types
Translational research to full CDx co-development
Our building blocks for robust diagnostics
Eighty-one leading academic institutions and pathology labs with secured data access.
Thirteen countries that ensure diverse cohorts.
Thirty-three therapeutic indications in oncology, immunology and inflammation, with leading KOLs in each field.
Breakthrough models built on a foundation of 8+ years of R&D with 59 tier 1 peer-reviewed articles.
Maximizing performance and generalizability with world-class foundation models and expertise in model fine-tuning.
Products undergo robust multicentric and international validations, across a variety of hardware and IT settings.
In-house quality management and niche experience in developing AI as fully approved IVDs for clinical use.
Robust infrastructure to obtain and maintain ISO certifications.
Audited by French health authorities certified (ANSM). GMED is our notified body.